Summary Notes WTO SPS and TBT
Summary Notes WTO SPS and TBT
Summary Notes WTO SPS and TBT
All governments accept the fact that some trade restrictions may be necessary to
ensure food safety and animal and plant health protection.
However, governments are sometimes pressured to go beyond what is needed for
health protection and to use sanitary and phytosanitary restrictions to shield
domestic producers from economic competition.
Such pressure is likely to increase as other trade barriers are reduced as a result of
the Uruguay Round agreements.
A sanitary or phytosanitary restriction which is not actually required for health
reasons can be a very effective protectionist device, and because of its technical
complexity, a particularly deceptive and difficult barrier to challenge.
The Agreement on Sanitary and Phytosanitary Measures (SPS) builds on previous
GATT rules to restrict the use of unjustified sanitary and phytosanitary measures
for the purpose of trade protection.
The basic aim of the SPS Agreement is to maintain the sovereign right of any
government to provide the level of health protection it deems appropriate, but to
ensure that these sovereign rights are not misused for protectionist purposes and
Page 1 of 10
Equivalence (article 4)
o SPS measures of an exporting country shall be accepted, even if they are
different from the measures required by the importing country, if they
achieve the importing countrys level of protection.
Page 3 of 10
could make no sense. The only reason could be discriminate and protect
national industry.
Page 4 of 10
The US EU beef hormones dispute was one of the first SPS case
The legal outcome hinged on a WTO finding that the EU did not conduct an
adequate risk assessment
The cases long evolution includes retaliation and compensation and it continues
to this day.
US was allowed to retaliate. The EU allow a quota of US hormone-free beef, but
it did not change the legislation, so this case is considered to be still open.
Measure at issue: EC prohibition on the placing on the market and the importation
of meat and meat products treated with certain hormones.
Products at issue: Meat and meat products treated with hormones for growth
purposes.
Page 5 of 10
Primary ruling: the WTO found that the EU moratorium on biotech approvals led
to undue delay. Thus, what it looked to be not important, the period of time for
approvals, in the biotech field turned to be critical.
Products at issue: Agricultural biotech products (GMOs) from the United States, Canada
and Argentina.
Summary of key panel/AB findings
General EC moratorium
SPS Arts. 5.1 and 2.2: The Panel found that the EC decision to apply a general
moratorium was a decision concerning the application/operation of approval procedures,
i.e., a procedural decision to delay final substantive approval decisions. It was not applied
for achieving the EC level of sanitary or phytosanitary protection and, hence, was not an
"SPS measure" subject to Arts. 5.1 or 2.2.
SPS Annex C(1)(a) and Art. 8: The Panel found that the general moratorium led to undue
delay in the completion of the EC approval procedure conducted in respect of at least one
biotech product at issue. Thus, European Communities acted inconsistently with Annex
C(1)(a) and, by implication, Art. 8. Product-specific measures
SPS Annex C(1)(a) and Art. 8: The Panel found that in 24 of the 27 product-specific
approval procedures it examined, the procedure had not been completed without undue
delay. In respect of these procedures, the European Communities had, therefore, acted
inconsistently with Annex C(1)(a) and, by implication, Art. 8.
EC member State safeguard measures
SPS Arts. 5.1, 2.2 and 5.7: According to the Panel, the record did not indicate that there
was insufficient evidence to conduct a risk assessment within the meaning of Art. 5.1 and
Page 6 of 10
Annex A(4) for the biotech products subject to safeguard measures. As a result, Arts. 5.1
and 2.2 were applicable. In this regard, the Panel found that none of the safeguard
measures at issue were based on a risk assessment as required under Art. 5.1 and defined
in Annex A(4). By maintaining measures contrary to Art. 5.1, the European Communities
had, by implication, also acted inconsistently with Art. 2.2.
Page 7 of 10
Page 8 of 10
Page 9 of 10
Page 10 of 10